Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
Perlegen Sciences
About
Perlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes.
- 51 - 100
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $74M
- Industries
- Biotechnology,Genetics,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2000
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Perlegen Sciences engages in the discovery and commercialization of genetic variations that provide physicians with information to improve the clinical decision-making process and patient treatment outcomes. Its products include MammaPLUS, a breast cancer risk stratifier and a panel of common genetic variants that stratifies individual genetic and background/clinical risk for those at moderately elevated risk for non-familial breast cancer, as well as impacts the risk for developing invasive breast cancer; and Genotype Browser Website that provides a way to access and view the results of a study of genetic variation in various diverse human populations. Perlegen Sciences, Inc. was founded in 2000 and is based in Mountain View, California.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 6, 2006 | Series D | $50M | 5 | — | — | Detail |
| Feb 28, 2005 | Series D | $74M | 5 | — | — | Detail |
| Jan 28, 2003 | Series C | $30M | 2 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
BSI SA
|
— | Series D |
|
|
— | Series D |
SB Life Science
|
— | Series D |
|
|
— | Series D |
Biofrontier Partners
|
— | Series D |
